Phase I/II Study of Lenalidomide (Revlimid), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R2CHOP) Chemoimmunotherapy in Patients With Newly Diagnosed Diffuse Large Cell and Follicular Grade IIIA/B B Cell Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 12 Jun 2018
At a glance
- Drugs Lenalidomide (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2018 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 06 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 May 2019.
- 28 Aug 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.